Patent Assignment
Reel/Frame 012772/0631
Change of Name
Recorded: 2002-03-29
Received: 2002-04-16
Pages: 10
Assignor
GENETICS INSTITUTE, INC.
Executed: 2002-01-01
Assignee
GENETICS INSTITUTE, LLC
87 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA, 02140, UNITED STATES
Covered Properties
(40)
Inhibitors of Phospholipase Enzymes
Application:
10/075,079 →
Chemical Strengthening Process for Disks Used in Disk Drive Data Storage Devices
Application:
10/116,340 →
Emulation of a High-Speed, High-Stability Clock
Application:
10/113,121 →
Aggrecanase molecules
Application:
10/057,487 →
Secreted protein, BA3.1, and polynucleotides encoding same
Application:
10/041,778 →
Secreted proteins and polynucleotides encoding them
Application:
10/040,916 →
GPI-122, a novel glycophosphatidylinositol-anchored protein
Application:
10/040,919 →
Neuronal uses of BMP-11
Application:
10/029,016 →
Highly Purified Mocarhagin, a Cobra Venom Protease, Polynucleotides Encoding Same and Related Proteases, and Therapeutic Uses Thereof
Application:
09/996,620 →
BONE MORPHOGENETIC PROTEIN-16 (BMP-16)Antibodies
Application:
09/994,177 →
Novel Tnf Receptor Death Domain Ligand Proteins and Inhibitors of Ligand Binding
Application:
09/989,350 →
Primers-Attached Vector Elongation (Pave): a 5'-Directed Cdna Cloning Strategy
Application:
10/007,357 →
Secreted proteins and polynucleotides encoding them
Application:
10/016,249 →
Novel Aggrecanase Molecules
Application:
09/981,953 →
Aggrecanase molecules
Application:
09/978,979 →
Bonus Game Points in a Gaming Environment
Application:
09/971,853 →
Antibody inhibitors of GDF-8 and uses thereof
Application:
60/324,528 →
Novel Protease Fmh-1
Application:
09/962,834 →
Novel P-Selectin Ligand Protein
Application:
09/935,144 →
Antibodies to Human INTERLE4UKIN-11 Receptor
Application:
09/924,338 →
Novel EBI-3-ALT protein and nucleic acid molecules and uses therefor
Application:
09/921,994 →
Inhibition of differentiation of cytotoxic T-cells by P-selectin ligand (PSGL) antagonists
Application:
09/904,710 →
Crystal Structure of Estrogen Receptor-Beta Complex and Uses Thereof
Application:
09/903,876 →
Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
Application:
09/902,535 →
Cytosolic Phospholipase A2-Beta Enzymes
Application:
09/895,547 →
Antibodies to Interleukin-1 Receptor Intracellular Ligand Proteins
Application:
09/884,319 →
Human Gdp-Mannose 4,6 Dehydratase
Application:
09/878,574 →
Receptor Proteins
Application:
09/874,628 →
Methods for purifying highly anionic proteins
Application:
60/296,402 →
Crystal Structures of P- Selectin, P- and E-Selectin Complexes, and Uses Thereof
Application:
09/859,722 →
Solution structure of TNFR-1 DD and uses thereof
Application:
09/854,906 →
Inhibition of thrombosis by treatment with P-selectin antagonists
Application:
09/825,580 →
N-TRADD active site and uses thereof
Application:
09/821,819 →
Methods for Purifying Highly Anionic Proteins
Application:
09/819,157 →
Bmp-6 Proteins
Application:
09/816,299 →
Use of rapamycin and agents that inhibit B7 activity in immunomodulation
Application:
09/805,800 →
Novel Bmp Products
Application:
09/804,625 →
Trade Molecules and Uses Related Thereto
Application:
09/780,532 →
Recombinant Bone Morphogenetic Protein Heterodimers, Compositions and Methods of Use
Application:
09/780,601 →
Antibodies Against CTLA4
Application:
09/772,103 →